More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association ...

Mechanical Heart Valve Replacements Have Better Long-Term ... Pregnancy Complications Linked to Cardiovascular Disease in the Family Feb. 7, 2025 — Women who have experienced pregnancy ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

The multisociety collaboration moves the focus from procedures to a continuum of care from diagnosis to any treatment ...

Patients receiving ataciguat tended to maintain better heart muscle function ... By slowing progression of the disease in the patient’s native aortic valve, ataciguat offers the potential ...

Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

The new device created by researchers at Georgia Tech and Emory hopes to change the treatment of heart valve disease forever.

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Researchers at Georgia Tech have developed 3D printed bioresorbably heart valves that could benefit patients with heart valve disease.